• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

P.T.Jyothi Datta

Mumbai, Oct. 1

The Institute of Clinical Research (India) is set to get financial support from ICICI Bank for a dedicated clinical research institute that would come up in Bangalore. Looking to invest in the growing opportunity of clinical research, ICICI Bank has approved a Rs-18-crore-loan towards setting up the dedicated clinical research institute, Mr S.R.Dugal, ICRI Chairman told Business Line.

The new campus will have facilities such as molecular biology laboratories; bio-equivalence labs that would conduct Phase I studies (where a drug is exposed to humans for the first time) and research units for Phase II and Phase III studies (where a medicine is exposed to a larger number of humans), he said. Students would be able to participate on actual clinical trials that their faculty would undertake, he said.

Translational medicine, where an attempt to is made to link research directly to patients, is another increasingly relevant segment that the institute seeks to offer, he said.

The process to procure land in Bangalore is under way and work is expected to start by December, he said. The institute should be up and running in a year after that, he said.

On offer is a two-year course for the 200 students that would be taken every year. The faculty would stay on campus, which would also have hostel facilities.

ICRI is a society and clinical research institutes promoted by it are at Delhi, Mumbai, Bangalore and Ahmedabad.

ICRI has an academic alliance with the United Kingdom’s Cranfield University and it’s head of translational medicine, Dr Anthony Woodman would join ICRI as its new Chief Executive Officer from November, Mr Dugal said.

The post had been vacant at ICRI from earlier this year when the previous CEO quit.

More Stories on : Credit Market | Research & Development | Bio-tech & Genetics | Pharmaceuticals | ICICI Bank Ltd

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Govt looking at full refund of levies: Kamal Nath

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line